Skip to Main Content

Paper Details

ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.
Nat Genet
125
2020
Author NameAffiliation
Pier SelenicaMemorial Sloan Kettering Cancer Center
Erik LadewigMemorial Sloan Kettering Cancer Center
Erik LadewigMemorial Sloan Kettering Cancer Center
Arnaud Da Cruz PaulaMemorial Sloan Kettering Cancer Center
Richard KocheCenter for Epigenetics Research, Memorial Sloan Kettering Cancer Center
Richard KocheCenter for Epigenetics Research, Memorial Sloan Kettering Cancer Center
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
Christina S LeslieMemorial Sloan Kettering Cancer Center
José BaselgaMemorial Sloan Kettering Cancer Center
José BaselgaMemorial Sloan Kettering Cancer Center
José BaselgaAstraZeneca Pharmaceuticals
  • 1 - 11

Datasets

Release 1.2